Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

Sch B may inhibit the development of HCC by inhibiting the expression of exosomal FN1during interactions between macrophages and HCC cells.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-03-28
DOI
https://doi.org/10.3389/fphar.2025.1547685
Primary Topic
Plant-derived Lignans Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

Qi Ling, Tieli Peng, Jie Yang, Wei Li et al.
Frontiers in Pharmacology
Plant-derived Lignans Synthesis and Bioactivity
article

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

Qi Ling, Tieli Peng, Jie Yang, Wei Li, Qingtian Huang, Qian Peng, Baoyi Jiang, Leyi Yao, Huoye Gan
article en

Abstract

Sch B may inhibit the development of HCC by inhibiting the expression of exosomal FN1during interactions between macrophages and HCC cells.

Frontiers in PharmacologyVol. 16
Guangdong Medical College (CN), Central People's Hospital of Zhanjiang (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 95%
Plant-derived Lignans Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.